Medigen Vaccine Biologics Corp.TPEX: 6547

Announcement of the company's board of directors resolution of cash capital increase issue of new shares

· Issued by Medigen Vaccine Biologics Corp.
Close
Today's Information

Provided by: Medigen Vaccine Biologics Corporation
SEQ_NO 1 Date of announcement 2022/03/01 Time of announcement 16:13:52
Subject
 Announcement of the company's board of directors
resolution of cash capital increase issue of new shares
Date of events 2022/03/01 To which item it meets paragraph 11
Statement
1.Date of the board of directors resolution:2022/03/01
2.Source of capital increase funds:
 Cash capital increase to issue new shares
3.Whether to adopt shelf registration
  (Yes, please state issuance period/No):No
4.Total monetary value of the issuance and number of shares issued (shares
 issued not including those distributed to employees if consisting in
 capital increase from earnings or capital surplus):
 Total monetary value of the issuance:NTD 70,000,000
 Number of shares issued:7,000,000 shares
5.If adopting shelf registration, monetary value and number of shares
to be issued this time:N/A
6.The remaining monetary value and shares after this issuance when
adopting shelf registration:N/A
7.Par value per share:NTD 10
8.Issue price:
 After the declaration by the competent authority becomes effective, the
 chairman is authorized to consult with the lead underwriters in accordance
 with the provisions of paragraph 1 of Article 6 of the Self-Regulatory
 Rules in consideration of the issuance market condition.
9.Number of shares subscribed for by or allocated to employees:
 According to Article 267 of the Company Act, 10% of the newly issued
 shares,which amounts to 700,000 shares are reserved for employees'
 subscription
10.Number of shares publicly sold:
 10% of the newly issued shares, which amounts to 700,000 shares are
 reserved for subscription by the public.
11.Ratio of shares subscribed by or allotted as stock
dividends to existing shareholders:
 80% of the newly issued shares, which amounts to 5,600,000 shares
 are reserved for subscription by existing shareholders according
 to their respective shareholding percentage as stated in
 shareholder register on the record date for share subscription.
12.Handling method for fractional shares and shares
unsubscripted for by the deadline:
 Fractions of shares less than one share subscribed for by
 existing shareholders may be combined and rounded to one share
 at Company's stock affairs agency within five days from the book
 closure date. If the existing shareholders and employees waived
 the fractional shares, the chairman is authorized to arrange
designated individuals to subscribe at the issue price.
13.Rights and obligations of these newly issued shares:
 The rights and obligations of this capital increase are the
 same as those of the existing issued common shares.
14.Utilization of the funds from the capital increase:
 Enrichment of working capital
15.Any other matters that need to be specified:
(1)The Chairman was authorized by the board of directors to modify or adjust
   the cash capital increase plan based on regulations, instructions of the
   competent authority, or objective circumstance requirements, including
   but not limited to the issuance price, purposes of the plan,
   implementation schedule, and expected returns and all matters related to
   the issuing plan.
(2)After the cash capital increase plan has been approved by FSC, the
   Chairman was authorized by the board of directors to decide the record
   date of the subscription of new shares, record date of capital increase,
   payment period, and other related matters of capital raising plan.

Company analysis